HRT FINANCIAL LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2022$3,393
-99.9%
43,145
-22.8%
0.05%
+20.0%
Q2 2022$3,642,000
+514.2%
55,878
+399.0%
0.04%
+1233.3%
Q4 2021$593,000
-67.6%
11,197
-32.1%
0.00%
-84.2%
Q1 2021$1,829,000
-46.2%
16,485
-56.6%
0.02%
-81.4%
Q2 2020$3,402,000
+186.4%
37,989
+267.3%
0.10%
+100.0%
Q4 2019$1,188,000
-17.4%
10,342
-9.3%
0.05%
-25.0%
Q3 2019$1,438,000
+95.6%
11,402
+35.6%
0.07%
-40.4%
Q1 2019$735,0008,4080.11%
Other shareholders
HAEMONETICS CORP shareholders Q1 2021
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders